---
$id: https://graph.org.ai/products/commodity/51111658
$type: Product
source: UNSPSC
code: "51111658"
title: "Tiazofurin or tiazofurine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tiazofurin or tiazofurine

**UNSPSC Code**: 51111658
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and inosine monophosphate dehydrogenase inhibitor with the molecular formula C9H12N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ULJ82834RE, chemically known as 4-thiazolecarboxamide, 2-.beta.-d-ribofuranosyl- but generally known as tiazofurin, which bears US NIH Compound Identifier 323701. European Medicines Agency schedules Tiazofurin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27111. The term TIAZOFURINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules tiazofurin in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TIAZOFURIN remains the US FDA Preferred Term for this commodity. Tiazofurin bears US NLM identifiers UMLS ID C0076656 and NCI Concept Code C1254. SMILES: S1C(NC(C1)C(=O)N)C1OC(C(O)C1O)CO.

